nafamostat has been researched along with Dengue in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Dengue: An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rathore, AP | 1 |
| Mantri, CK | 1 |
| Aman, SA | 1 |
| Syenina, A | 1 |
| Ooi, J | 1 |
| Jagaraj, CJ | 1 |
| Goh, CC | 1 |
| Tissera, H | 1 |
| Wilder-Smith, A | 1 |
| Ng, LG | 1 |
| Gubler, DJ | 1 |
| St John, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients: a Multicenter Randomized, Double-blind, Placebo Controlled, Superiority Trial[NCT04673422] | Phase 2/Phase 3 | 358 participants (Actual) | Interventional | 2021-01-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for nafamostat and Dengue
| Article | Year |
|---|---|
Dengue virus-elicited tryptase induces endothelial permeability and shock.
Topics: Animals; Benzamidines; Capillary Permeability; Cell Line; Dengue; Dengue Virus; Endothelium, Vascula | 2019 |